Scabies outbreaks in nursing homes for the elderly: Recognition, treatment options and control of reinfestation

Drugs and Aging

Volumn 25, Issue 4, 2008, Pages 299-306

  Tjioe, Milan ^a   Vissers, Wynand H P M ^b  

^a GELRE HOSPITALS   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Benzyl benzoate, therapeutic use; Elderly; Ivermectin, therapeutic use; Lindane, therapeutic use; Malathion, therapeutic use; Permethrin, therapeutic use; Scabies, treatment

Indexed keywords

BENZYL BENZOATE; CROTAMITON; ESSENTIAL OIL; IVERMECTIN; LINDANE; LIPPIA MULTIFLORA EXTRACT; MALATHION; PERMETHRIN; PLANT EXTRACT; TEA TREE OIL; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DOSE RESPONSE; DRUG CARCINOGENICITY; ELDERLY CARE; EPIDEMIC; HUMAN; LIFE CYCLE; MACULOPAPULAR RASH; MUSCLE SPASM; NEUROTOXICITY; NONHUMAN; NURSING HOME; PRIORITY JOURNAL; PRURITUS; REVIEW; SARCOPTES SCABIEI; SCABIES; SINGLE DRUG DOSE; SKIN IRRITATION; UNSPECIFIED SIDE EFFECT;

EID: 41149162051     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825040-00003     Document Type: Review

References (48)

1. Holness DL, DeKoven JG, Nethercott JR. Scabies in chronic health care institutions. Arch Dermatol 1992; 128: 1257-60
2. Koene RP, Tjioe M, Hoondert K, et al. Scabies outbreak in a hospital and in 8 health-care institutions caused by an elderly patient with scabies crustosa [in Dutch]. Ned Tijdschr Geneeskd 2006; 150: 918-23
3. Tan HH, Goh CL. Parasitic skin infections in the elderly: recognition and drug treatment. Drugs Aging 2001; 18: 165-76
4. Burgess I. Sarcoptes scabiei and scabies. Adv Parasitol 1994; 33: 235-92
5. Haag ML, Brozena SJ, Fenske NA. Attack of the scabies: what to do when an outbreak occurs. Geriatrics 1993; 48: 45-3
6. Arlian LG, Runyan RA, Achar S, et al. Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol 1984; 11: 210-5
7. Arlian LG. Biology, host relations, and epidemiology of Sarcoptes scabiei. Annu Rev Entomol 1989; 34: 139-61
8. Hengge UR, Currie BJ, Jager G, et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis 2006; 6: 769-79
9. Sunderkotter C, Mayser P, Folster-Holst R, et al. Scabies. J Dtsch Dermatol Ges 2007; 5: 424-30
10. Chosidow O. Scabies and pediculosis. Lancet 2000; 355: 819-26
11. Scott FP, Lups JG. Scabies: a historical review and description of a case of scabies norvegica. S Afr Med J 1970; 44: 66-9
12. Roberts LJ, Huffam SE, Walton SF, et al. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005; 50: 375-81
13. O'Donnell BF, O'Loughlin S, Powell FC. Management of crusted scabies. Int J Dermatol 1990; 29: 258-66
14. Savin JA. Scabies in Edinburgh from 1815 to 2000. J Soc Med 2005; 98: 124-9
15. Mimouni D, Ankol OE, Davidovitch N, et al. Seasonality trends of scabies in a young adult population: a 20-year follow-up. Br J Dermatol 2003; 149: 157-9
16. Badiaga S, Menard A, Tissot DH, et al. Prevalence of skin infections in sheltered homeless. Eur J Dermatol 2005; 15: 382-6
17. Walton SF, McBroom J, Mathews JD, et al. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis 1999; 29: 1226-30
18. Tsutsumi M, Nishiura H, Kobayashi T. Dementia-specific risks of scabies: retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Japan from 1989-90. BMC Infect Dis 2005; 5: 85
19. Savin JA. Mellanby on scabies. Clin Exp Dermatol 2002; 27: 86-7
20. Gimenez GR, de la Lama Lopez-Areal J, Avellaneda MC. Scabies in the elderly. J Eur Acad Dermatol Venereol 2004; 18: 105-7
21. Dupuy A, Dehen L, Bourrat E, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007; 56: 53-62
22. Katsumata K, Katsumata K. Simple method of detecting Sarcoptes scabiei var hominis mites among bedridden elderly patients suffering from severe scabies infestation using an adhesive-tape. Intern Med 2006; 45: 857-9
23. Woodley D, Saurat JH. The burrow ink test and the scabies mite. J Am Acad Dermatol 1981; 4: 715-22
24. Strong M, Johnstone P. Interventions for treating scabies. Cochrane Database Syst Rev 2007; 3: CD000320
25. Boffa MJ, Brough PA, Ead RD. Lindane neurotoxicity [letter]. Br J Dermatol 1995; 133: 1013
26. Friedman GD. Lindane and cancer in humans: a false alarm? Pharmacoepidemiol Drug Saf 1997; 6 (2): 129-34
27. Katsumata K, Katsumata K. Norwegian scabies in an elderly patient who died after treatment with gammaBHC. Intern Med 2003; 42: 367-9
28. Coleman CI, Gillespie EL, White CM. Probable topical permethrin-induced neck dystonia. Pharmacotherapy 2005; 25: 448-50
29. Moeller HC, Rider JA. Plasma and red blood cell cholinesterase activity as indications of the threshold of incipient toxicity of ethyl-p-nitrophenyl thionobenzenephosphonate (EPN) and malathion in human beings. Toxicol Appl Pharmacol 1962; 4: 123-30
30. Taplin D, Meinking TL, Chen JA, et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7: 67-73
31. Leppard B, Naburi AE. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol 2000; 143: 520-3
32. Chouela EN, Abeldano AM, Pellerano G, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999; 135: 651-5
33. laziou P, Cartel JL, Alzieu P, et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993; 44: 331-2
34. Meinking TL, Taplin D, Hermida JL, et al. The treatment of scabies with ivermectin. N Engl J Med 1995; 333: 26-30
35. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997; 349: 1144-5
36. Bredal WP. Deaths associated with ivermectin for scabies [letter]. Lancet 1997; 350: 216
37. Coyne PE, Addiss DG. Deaths associated with ivermectin for scabies. Lancet 1997; 350: 215-6
38. Diazgranados JA, Costa JL. Deaths after ivermectin treatment [letter]. Lancet 1997; 349: 1698
39. Reintjes R, Hoek C. Deaths associated with ivermectin for scabies [letter]. Lancet 1997; 350: 215
40. Santoro AF, Rezac MA, Lee JB. Current trend in ivermectin usage for scabies. J Drugs Dermatol 2003; 2 (4): 397-401
41. Tomalik-Scharte D, Lazar A, Meins J, et al. Dermal absorption of permethrin following topical administration. Eur J Clin Pharmacol 2005; 61: 399-404
42. Guldbakke KK, Khachemoune A. Crusted scabies: a clinical review. J Drugs Dermatol 2006; 5: 221-7
43. Oladimeji FA, Orafidiya OO, Ogunniyi TA, et al. Pediculocidal and scabicidal properties of Lippia multiflora essential oil. J Ethnopharmacol 2000; 72: 305-11
44. Walton SF, McKinnon M, Pizzutto S, et al. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 2004; 140: 563-6
45. Tarigan S, Huntley JF. Failure to protect goats following vaccination with soluble proteins of Sarcoptes scabiei: evidence for a role for IgE antibody in protection. Vet Parasitol 2005; 133: 101-9
46. Walton SF, Choy JL, Bonson A, et al. Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabies-endemic communities Australia. Am J Trop Med Hyg 1999; 61: 542-7
47. Witkowski JA, Parish LC. Lindane-resistant scabies [letter]. J Am Acad Dermatol 1992; 27: 648
48. Currie BJ, Harumal P, McKinnon M, et al. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004; 39: e8-12